| 15/09/26 | 07:00:01 | 15 Sept 2026 | | Half-year Financial Report | RNS |
| 10/08/26 | 07:00:06 | 10 Aug 2026 | | Cytolytix Patent Update | RNS |
| 17/07/26 | 12:25:01 | 17 Jul 2026 | | Result of AGM, Warrants & Directorate Change | RNS |
| 22/06/26 | 07:00:11 | 22 Jun 2026 | | Conclusion of Evaluation with University of Dundee | RNS |
| 22/06/26 | 07:00:09 | 22 Jun 2026 | | Final Results & Notice of AGM | RNS |
| 02/06/26 | 07:00:05 | 2 Jun 2026 | | Conclusion of Evaluation with Stingray | RNS |
| 01/06/26 | 07:00:12 | 1 Jun 2026 | | ValiRx Exercises Option on Evaluation Asset | RNS |
| 27/05/26 | 07:00:06 | 27 May 2026 | | Cytolytix Patent Granted | RNS |
| 21/05/26 | 07:00:06 | 21 May 2026 | | Result of Oversubscribed WRAP Retail Offer | RNS |
| 18/05/26 | 07:00:10 | 18 May 2026 | | WRAP Retail Offer for up to £150,000 | RNS |
| 15/05/26 | 07:00:04 | 15 May 2026 | | Fundraising of up to £1,155,000 | RNS |
| 31/03/26 | 10:15:00 | 31 Mar 2026 | | Change of Registered Office | RNS |
| 26/03/26 | 07:00:05 | 26 Mar 2026 | | ValiRx Commercial Update Q1 2026 | RNS |
| 24/03/26 | 07:00:12 | 24 Mar 2026 | | ValiRx and TwinEdge to present Digital Twin data | RNS |
| 04/03/26 | 07:00:09 | 4 Mar 2026 | | Director/PDMR Shareholding | RNS |
| 02/03/26 | 07:00:15 | 2 Mar 2026 | | ValiRx forms ValiRx Animal Health Ltd subsidiary | RNS |
| 19/01/26 | 07:00:05 | 19 Jan 2026 | | Exercise of Warrants | RNS |
| 09/01/26 | 15:45:00 | 9 Jan 2026 | | Replacement: Evaluation and Transfer Agreement | RNS |
| 09/01/26 | 07:00:05 | 9 Jan 2026 | | New Evaluation and Material Transfer Agreement | RNS |
| 08/01/26 | 13:00:00 | 8 Jan 2026 | | Holding(s) in Company | RNS |
| 05/12/25 | 10:56:01 | 5 Dec 2025 | | Holding(s) in Company | RNS |
| 24/11/25 | 15:54:14 | 24 Nov 2025 | | Holding(s) in Company | RNS |
| 24/11/25 | 09:30:01 | 24 Nov 2025 | | Holding(s) in Company | RNS |
| 20/11/25 | 12:11:58 | 20 Nov 2025 | | Result of GM & Issue of Equity | RNS |
| 13/11/25 | 14:16:00 | 13 Nov 2025 | | Holding(s) in Company | RNS |
| 10/11/25 | 07:00:10 | 10 Nov 2025 | | Holding(s) in Company | RNS |
| 04/11/25 | 17:15:44 | 4 Nov 2025 | | Posting of Circular and Notice of General Meeting | RNS |
| 04/11/25 | 07:00:11 | 4 Nov 2025 | | Result of WRAP Retail Offer | RNS |
| 30/10/25 | 07:21:14 | 30 Oct 2025 | | WRAP Retail Offer for up to £300,000 | RNS |
| 30/10/25 | 07:17:30 | 30 Oct 2025 | | Fundraising of up to £1,050,000 | RNS |
| 14/10/25 | 07:00:08 | 14 Oct 2025 | | Inaphaea Commercial update | RNS |
| 29/09/25 | 07:00:12 | 29 Sept 2025 | | Half-year Report | RNS |
| 18/09/25 | 07:00:09 | 18 Sept 2025 | | Inaphaea Commercial Update | RNS |
| 01/09/25 | 07:00:10 | 1 Sept 2025 | | Cytolytix Commercial update | RNS |
| 26/08/25 | 07:00:12 | 26 Aug 2025 | | Commercial update | RNS |
| 07/08/25 | 10:51:16 | 7 Aug 2025 | | ValiRx Awarded Grant from Open University | RNS |
| 05/08/25 | 09:53:20 | 5 Aug 2025 | | Update on Evaluation Agreement with Stingray Bio | RNS |
| 04/08/25 | 07:00:13 | 4 Aug 2025 | | Licensing Agreement with Dominion Biotech Ltd | RNS |
| 29/07/25 | 07:00:10 | 29 Jul 2025 | | Collaboration Agreement with Voxcell BioInnovation | RNS |
| 30/06/25 | 15:48:43 | 30 Jun 2025 | | Result of AGM | RNS |
| 20/06/25 | 07:00:02 | 20 Jun 2025 | | Ambrose Exercise Option on VAL401 | RNS |
| 09/06/25 | 10:57:09 | 9 Jun 2025 | | ValiRx Investor Webinar | RNS |
| 06/06/25 | 10:54:37 | 6 Jun 2025 | | Holding(s) in Company | RNS |
| 06/06/25 | 07:00:11 | 6 Jun 2025 | | Final Results & Notice of AGM | RNS |
| 03/06/25 | 07:00:09 | 3 Jun 2025 | | New Evaluation and Material Transfer Agreement | RNS |
| 20/05/25 | 13:25:16 | 20 May 2025 | | Holding(s) in Company | RNS |
| 12/05/25 | 07:00:08 | 12 May 2025 | | Inaphaea Deal Extension With Dominion | RNS |
| 30/04/25 | 07:00:09 | 30 Apr 2025 | | Commercial Update | RNS |
| 03/04/25 | 07:00:09 | 3 Apr 2025 | | Termination of Letter of Intent with TheoremRx | RNS |
| 27/03/25 | 07:00:15 | 27 Mar 2025 | | Directorate Changes and new Advisory Board | RNS |
